Source Legend
- Human-provided
Entered or confirmed by an authorized person.
- Google
Imported Google information.
- Trial-derived
Calculated or extracted directly from associated trial records.
- AI-inferred
A capability inferred from trial history.
- AI-extracted
An explicit statement extracted from an official source.
- Public registry
Information from a public registry.
- Site record
Information held in the site record.
Source: Site record. WellSpan Medical Oncology & Hematology - Hanover

Claim This Site
Are you the site administrator? Claim this site to update information.
Basic Information
Site Overview
WellSpan Medical Oncology & Hematology – Hanover is a community-based oncology care facility located at 671 Wilson Avenue, Hanover, Pennsylvania, and is part of the WellSpan Health network. The site provides specialized medical oncology and hematology services, supporting patients with a range of cancers and blood disorders through individualized treatment planning and coordinated care. Its services include advanced cancer treatments such as chemotherapy, immunotherapy, targeted therapy, and hormone therapy, with support from oncology specialists and nurse navigators. Through the broader WellSpan Cancer Institute, the facility is connected to a multidisciplinary cancer care network that collaborates with Johns Hopkins Medicine’s Kimmel Cancer Center, offering access to specialized expertise and clinical trial opportunities.
Business Status
Business Category
Business Subcategory
Affiliations
Affiliated Groups
Associated Organizations
Conditions
Sponsors
Imaging & Diagnostics
Imaging and diagnostic capabilities inferred from trial participation
Laboratory & Biospecimens
Laboratory and biospecimen capabilities inferred from trial participation
Research Pharmacy & Investigational Product
Investigational-product capabilities inferred from trial participation
Clinical Procedures
Clinical procedures inferred from trial participation
Accessibility & Parking
Accessibility Features
Additional Capabilities
Other capabilities inferred from trial participation